Martin Bezdíčka1, Šárka Štolbová1, Tomáš Seeman1, Ondřej Cinek2, Michal Malina1, Naděžda Šimánková1, Štěpánka Průhová1, Jakub Zieg1. 1. Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, V Uvalu 84, Prague, Czech Republic. 2. Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, V Uvalu 84, Prague, Czech Republic. ondrej.cinek@fnmotol.cz.
Abstract
BACKGROUND: Steroid-resistant nephrotic syndrome (SRNS) has a heterogeneous spectrum of monogenic causes that substantially differ among populations. The aim of this study was to analyse the genetic aetiology of SRNS in Czech and Slovak paediatric patients. METHODS: We analysed clinical data from 74 patients (38 boys) with congenital (15%), infant (14%), and childhood-onset (71%) SRNS collected from the Czech Republic and Slovakia from 2000 to 2017 (inclusive). The DNA samples were first analysed by Sanger sequencing (genes NPHS2, NPHS1, and WT1) and then by next generation sequencing (NGS) using a targeted panel of 48 genes previously associated with SRNS. Family segregation of the causative variants was confirmed by Sanger sequencing when possible. RESULTS: Genetic diagnosis was established in 28/74 patients (38%) based on findings of pathogenic or likely pathogenic causative variants in genotypes conforming to the expected mode of inheritance. Sanger sequencing diagnosed 26% of patients, whereas second-tier testing by a targeted NGS panel diagnosed a further 12%. Frequent causative genes were NPHS2 (15%), WT1 (9.5%), and surprisingly NUP93 with four (5.4%) unrelated cases. Additional causative genes included COQ2 (two patients), NPHS1, INF2, DGKE, and LMX1B (one patient each). CONCLUSIONS: Compared with outright use of NGS, our tiered genetic testing strategy was considerably more rapid and marginally less expensive. Apart from a high aetiological fraction of NPHS2 and WT1 genes, our study has identified an unexpectedly high frequency of a limited set of presumably ancestral causative mutations in NUP93. The results may aid in tailoring testing strategies in Central European populations.
BACKGROUND:Steroid-resistant nephrotic syndrome (SRNS) has a heterogeneous spectrum of monogenic causes that substantially differ among populations. The aim of this study was to analyse the genetic aetiology of SRNS in Czech and Slovak paediatric patients. METHODS: We analysed clinical data from 74 patients (38 boys) with congenital (15%), infant (14%), and childhood-onset (71%) SRNS collected from the Czech Republic and Slovakia from 2000 to 2017 (inclusive). The DNA samples were first analysed by Sanger sequencing (genes NPHS2, NPHS1, and WT1) and then by next generation sequencing (NGS) using a targeted panel of 48 genes previously associated with SRNS. Family segregation of the causative variants was confirmed by Sanger sequencing when possible. RESULTS: Genetic diagnosis was established in 28/74 patients (38%) based on findings of pathogenic or likely pathogenic causative variants in genotypes conforming to the expected mode of inheritance. Sanger sequencing diagnosed 26% of patients, whereas second-tier testing by a targeted NGS panel diagnosed a further 12%. Frequent causative genes were NPHS2 (15%), WT1 (9.5%), and surprisingly NUP93 with four (5.4%) unrelated cases. Additional causative genes included COQ2 (two patients), NPHS1, INF2, DGKE, and LMX1B (one patient each). CONCLUSIONS: Compared with outright use of NGS, our tiered genetic testing strategy was considerably more rapid and marginally less expensive. Apart from a high aetiological fraction of NPHS2 and WT1 genes, our study has identified an unexpectedly high frequency of a limited set of presumably ancestral causative mutations in NUP93. The results may aid in tailoring testing strategies in Central European populations.
Authors: Agnieszka Bińczak-Kuleta; Jacek Rubik; Mieczysław Litwin; Małgorzata Ryder; Klaudyna Lewandowska; Olga Taryma-Leśniak; Jeremy S Clark; Ryszard Grenda; Andrzej Ciechanowicz Journal: Bosn J Basic Med Sci Date: 2014-05 Impact factor: 3.363
Authors: Agnes Trautmann; Monica Bodria; Fatih Ozaltin; Alaleh Gheisari; Anette Melk; Marta Azocar; Ali Anarat; Salim Caliskan; Francesco Emma; Jutta Gellermann; Jun Oh; Esra Baskin; Joanna Ksiazek; Giuseppe Remuzzi; Ozlem Erdogan; Sema Akman; Jiri Dusek; Tinatin Davitaia; Ozan Özkaya; Fotios Papachristou; Agnieszka Firszt-Adamczyk; Tomasz Urasinski; Sara Testa; Rafael T Krmar; Lidia Hyla-Klekot; Andrea Pasini; Z Birsin Özcakar; Peter Sallay; Nilgun Cakar; Monica Galanti; Joelle Terzic; Bilal Aoun; Alberto Caldas Afonso; Hanna Szymanik-Grzelak; Beata S Lipska; Sven Schnaidt; Franz Schaefer Journal: Clin J Am Soc Nephrol Date: 2015-01-29 Impact factor: 8.237
Authors: Heon Yung Gee; Pawaree Saisawat; Shazia Ashraf; Toby W Hurd; Virginia Vega-Warner; Humphrey Fang; Bodo B Beck; Olivier Gribouval; Weibin Zhou; Katrina A Diaz; Sivakumar Natarajan; Roger C Wiggins; Svjetlana Lovric; Gil Chernin; Dominik S Schoeb; Bugsu Ovunc; Yaacov Frishberg; Neveen A Soliman; Hanan M Fathy; Heike Goebel; Julia Hoefele; Lutz T Weber; Jeffrey W Innis; Christian Faul; Zhe Han; Joseph Washburn; Corinne Antignac; Shawn Levy; Edgar A Otto; Friedhelm Hildebrandt Journal: J Clin Invest Date: 2013-07-08 Impact factor: 14.808
Authors: Francesca Diomedi-Camassei; Silvia Di Giandomenico; Filippo M Santorelli; Gianluca Caridi; Fiorella Piemonte; Giovanni Montini; Gian Marco Ghiggeri; Luisa Murer; Laura Barisoni; Anna Pastore; Andrea Onetti Muda; Maria Luisa Valente; Enrico Bertini; Francesco Emma Journal: J Am Soc Nephrol Date: 2007-09-12 Impact factor: 10.121
Authors: Anja K Büscher; Bodo B Beck; Anette Melk; Julia Hoefele; Birgitta Kranz; Daniel Bamborschke; Sabrina Baig; Bärbel Lange-Sperandio; Theresa Jungraithmayr; Lutz T Weber; Markus J Kemper; Burkhard Tönshoff; Peter F Hoyer; Martin Konrad; Stefanie Weber Journal: Clin J Am Soc Nephrol Date: 2015-12-14 Impact factor: 8.237
Authors: Elizabeth J Brown; Johannes S Schlöndorff; Daniel J Becker; Hiroyasu Tsukaguchi; Stephen J Tonna; Andrea L Uscinski; Henry N Higgs; Joel M Henderson; Martin R Pollak Journal: Nat Genet Date: 2009-12-20 Impact factor: 38.330
Authors: Daniela A Braun; Carolin E Sadowski; Stefan Kohl; Svjetlana Lovric; Susanne A Astrinidis; Werner L Pabst; Heon Yung Gee; Shazia Ashraf; Jennifer A Lawson; Shirlee Shril; Merlin Airik; Weizhen Tan; David Schapiro; Jia Rao; Won-Il Choi; Tobias Hermle; Markus J Kemper; Martin Pohl; Fatih Ozaltin; Martin Konrad; Radovan Bogdanovic; Rainer Büscher; Udo Helmchen; Erkin Serdaroglu; Richard P Lifton; Wolfram Antonin; Friedhelm Hildebrandt Journal: Nat Genet Date: 2016-02-15 Impact factor: 38.330
Authors: Martin Bezdicka; Filip Kaufman; Ivana Krizova; Alzbeta Dostalkova; Michaela Rumlova; Tomas Seeman; Karel Vondrak; Filip Fencl; Jakub Zieg; Ondrej Soucek Journal: Sci Rep Date: 2022-05-24 Impact factor: 4.996
Authors: Ibrahim Sandokji; Jonathan Marquez; Weizhen Ji; Cynthia A Zerillo; Monica Konstantino; Saquib A Lakhani; Mustafa K Khokha; Jillian K Warejko Journal: BMC Nephrol Date: 2019-07-17 Impact factor: 2.388
Authors: Aliaa H Abdelhakim; Avinash V Dharmadhikari; Sara D Ragi; Jose Ronaldo Lima de Carvalho; Christine L Xu; Amanda L Thomas; Christie M Buchovecky; Mahesh M Mansukhani; Ali B Naini; Jun Liao; Vaidehi Jobanputra; Irene H Maumenee; Stephen H Tsang Journal: Orphanet J Rare Dis Date: 2020-11-13 Impact factor: 4.123
Authors: Rachel K Cason; Anna Williams; Megan Chryst-Stangl; Guanghong Wu; Kinsie Huggins; Kaye E Brathwaite; Brandon M Lane; Larry A Greenbaum; Vivette D D'Agati; Rasheed A Gbadegesin Journal: Front Pediatr Date: 2022-07-07 Impact factor: 3.569